Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ('Olema' or 'Olema Oncology', Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to 11 new employees to purchase an aggregate of 322,000 shares of the Company's common stock, effective as of June 2, 2025. These awards were approved by the Compensation Committee of Olema's Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
The stock options vest over four years, with 25 percent vesting on the first anniversary of the vesting commencement date for such employee and the remainder vesting in 36 equal monthly installments over the following three years, subject to the employee being continuously employed by Olema as of such vesting dates. The stock options have a 10-year term and an exercise price of $4.38 per share, equal to the last reported sale price of the Company's common stock as reported by Nasdaq on June 2, 2025. The stock options are subject to the terms of the Olema Pharmaceuticals, Inc., 2022 Inducement Plan.
Olema is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4).
About Olema OncologyOlema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD), currently in a Phase 3 clinical trial called OPERA-01. In addition, Olema is developing OP-3136, a potent lysine acetyltransferase 6 (KAT6) inhibitor, now in a Phase 1 clinical trial. Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit www.olema.com.
Media and Investor Relations ContactCourtney O'KonekVice President, Corporate CommunicationsOlema Oncologymedia@olema.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Factbox-UK Market Exodus: Companies that have moved away from a London listing
(Reuters) -British money transfer firm Wise became the latest UK listed firm on Thursday to say that it intends to move its primary listing to the U.S. from London. A growing number of companies have shelved or shifted plans to list in London, due to investor pushback and Brexit-related challenges that have pressured UK market valuations. Instead, they have opted for the U.S. and other markets, where they see stronger appetite and higher valuations. Cobalt: The Glencore-backed metals investor scrapped its plans for a London IPO on Wednesday, which, according to one source, was driven by a lack of demand. The company, valued at around $230 million, would have seen London's largest market debut since Air Astana's listing in February 2024. Indivior: The drugmaker said on Monday it will cancel its secondary listing on the London Stock Exchange effective July 25, citing cost savings and a desire to align more closely with its U.S.-focused operations. The 1.25 billion pound ($1.70 billion) pharmaceutical firm will retain its primary listing on the Nasdaq. BHP: The world's largest miner by market value ($125.10 billion) made Australia its primary stock market when it ended its dual-listing structure in 2021. The company was the second largest by market value in London when it left the stock market. Unilever: The Ben & Jerry's maker in February picked Amsterdam as the primary listing for its ice cream business. The business, which generated a turnover of 8.3 billion euros ($9.47 billion) in 2024, will have secondary listings in London and New York. Glencore: The Swiss miner said in February it was considering moving its primary listing from London. The company, with a market value of 34.5 billion pounds, said New York was at the top of the list under consideration. Shein: The online fast fashion retailer is working towards a listing in Hong Kong after its proposed initial public offering (IPO) in London failed to secure the green light from Chinese regulators, three sources with knowledge of the matter told Reuters in May. However, before its attempt to list in London, Shein had pursued a listing in New York, as part of its efforts to gain legitimacy as a global, rather than a Chinese company, and access to a wide pool of large Western investors. Ashtead: The second-largest equipment rental company in the U.S. said in December it plans to shift its listing to New York. With a market value of 18.3 billion pounds, Ashtead has been listed in London since 1986, and transformed into a major U.S. player in the early 2000s. Just Eat Takeaway: The Amsterdam-listed food delivery company delisted from the London Stock Exchange in December, citing efforts to reduce administrative and regulatory costs. The company has a market value of 4.05 billion euros. Flutter Entertainment: The FanDuel-owner in 2024 moved its primary listing to the New York Stock Exchange (NYSE), just a few months after it added a secondary listing in the US. CRH: The building materials solutions provider, which has $61.29 billion in market value, switched its primary listing to the NYSE in 2023, while maintaining a standard listing on the London Stock Exchange. Arm Holdings: The UK-based chip designer chose Nasdaq over London for its 2023 IPO — the largest of that year. The company, now valued at just over $138 billion, was previously listed in London for 18 years till 2016, when it was taken private by SoftBank in a $32 billion acquisition. ($1 = 0.8763 euros) ($1 = 0.7355 pounds) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
Lumination Hive Announces Launch of New Book on Resilient Leadership by Founder Brenna Davis
Portland, OR , June 05, 2025 (GLOBE NEWSWIRE) -- Lumination Hive, a leadership and strategy firm focused on resilient and regenerative business practices, today announced the upcoming release of Leading Through Fire: Resilient Leadership for People, Planet, and the Future. The book, authored by Lumination Hive founder and CEO Brenna Davis, will be released on June 24, DavisDavis currently serves as CEO of one of the nation's leading mission-driven companies, structured as a Perpetual Purpose Trust (PPT). She founded Lumination Hive to expand access to leadership tools that support systemic change, inclusive governance, and long-term impact across sectors. Leading Through Fire is designed to support leaders facing volatility across industries—from climate disruption and economic uncertainty to organizational change and social fragmentation. The book provides a field-tested framework for building adaptive, principle-driven leadership in challenging environments. Organized into nine concise chapters, the book includes: Practical reflections designed for leaders navigating real-time complexity Tools for aligning daily actions with long-term organizational purpose Strategies to build momentum and avoid burnout during extended uncertainty Frameworks for creating resilient systems rooted in trust and inclusivity Guidance on leading with clarity and compassion in times of disruption 'This book was developed in response to what organizations are navigating right now—constant change, rising expectations, and a need for leadership that balances decisiveness with care,' said Brenna Davis, founder of Lumination Hive and CEO of a Perpetual Purpose Trust–structured company. 'The content provides structure and clarity without oversimplifying the complexity of this moment.' Kevin Wilhelm, founder of Sustainable Business Consulting and bestselling author, endorsed the book:'Brenna's book has found a way to cut through to the heart of so many of our problems, by providing a blueprint for all leaders, and aspiring ones. She shows how best to lead to best achieve desired results with compassion, resilience and grace.' The book draws on more than two decades of experience in regenerative business strategy, stakeholder governance, and mission-aligned leadership. It reflects Lumination Hive's mission to help leaders and organizations navigate complexity, grow with integrity, and create lasting impact. Lumination Hive provides leadership consulting, executive coaching, keynote speaking, and publications for boards, founders, and purpose-driven teams. The firm supports organizations seeking alternatives to extractive business models by building durable cultures of trust, accountability, and regeneration. Leading Through Fire will be released on June 24, 2025. Early readers can join the waitlist now to receive updates and exclusive launch access. Join the waitlist and learn more at: Leading Through Fire: Resilient Leadership for People, Planet, and the Future Cover About Lumination Hive, LLC Lumination Hive exists to support leaders and organizations who are here to do the deep work of transformation, of integrity, of building the future. We are a strategy and leadership firm for the next economy, partnering with CEOs, founders, boards, and teams ready to lead with clarity and build with purpose. Our work lives at the intersection of regenerative leadership, alternative governance, and long-term strategy—because we believe the future belongs to those who can hold complexity without losing their center. Founded by Brenna Davis—CEO, environmental scientist, board leader, and author—Lumination Hive blends decades of real-world experience with frameworks that are fresh, practical, and deeply human. Press inquiries Lumination Hive, LLC Brenna Davis brennadavis@ 2069790251
Yahoo
19 minutes ago
- Yahoo
Apple EPS Faces 2--3% Hit After Epic Ruling
Apple (NASDAQ:AAPL) is bracing for a 23% EPS headwind after a federal appeals court upheld an injunction requiring link-out payments in the App Store, potentially shifting billions in developer fees over the next two years. Despite this ruling taking effect April 30, May App Store revenue climbed 13% overall (10% in the U.S.), suggesting many developers won't abandon Apple's ecosystem due to the convenience and trust of its billing. Evercore ISI's Amit Daryanani notes the App Store generates about $21 billion in annual sales, with roughly $7 billion of that coming from U.S. developer fees; while a complete fee loss would imply a 6% EPS hit, he expects a more modest impact as developers weigh higher alternative fees against Apple's seamless experience. J.P. Morgan's Samik Chatterjee agrees on a 2%3% EPS drag, citing an AlphaWise survey where 28% of U.S. iPhone users say they'd be extremely likely to link outputting roughly $3.7 billion in revenue at risk and translating to a worst-case 16-cent EPS hit (2%). Morgan Stanley's data also points to a 2% EPS exposure. Gaming accounts for about 65% of U.S. App Store sales, mostly $0.99 one-time purchases; if users switch to payment platforms like Stripe, they could end up paying 3% plus 30 cents per transactionoften more than Apple's 27% commission. Apple insists that over 90% of 2024 billings incurred no commission and emphasizes the App Store's role in helping developers reach a global audience. CEO Tim Cook highlighted that so many developers design great apps, build successful businesses, and reach Apple users through this platform. Investors should watch June App Store metrics and upcoming appellate developments to gauge the long-term financial fallout, since even a small EPS hit matters given Apple's $3 trillion valuation. In other news, Apple has tapped India's Tata Group to handle after-sales repairs for iPhones and MacBooks in India, taking over from Taiwan's Wistron unit, ICT Service Management Solutions. Tata already assembles iPhones at three South India facilitiesone of which produces certain partsand will now carry out repairs at its Karnataka assembly site. This ongoing transition underscores Apple's confidence in Tata as it diversifies manufacturing beyond China, where Tata also assembles devices for domestic and export markets. Apple, Wistron and Tata declined immediate comment. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
